Cell Models of Castration Resistant and High Dose Testosterone-Resistant Prostate Cancer Recapitulate the...

Area of Science:

• Oncology
• Endocrinology
• Cancer Biology

Background:

• Metastatic castration-resistant prostate cancer (CRPC) treatment often involves testosterone and anti-androgen agents.
• Understanding resistance mechanisms to this therapy is crucial for improving patient outcomes.

Purpose of the Study:

• To develop and characterize preclinical models for studying high-dose testosterone resistance in CRPC.
• To investigate the heterogeneity of responses to hormonal manipulation in CRPC.

Main Methods:

• Derived three distinct testosterone-sensitive CRPC cell lines.
• Selected and established high-dose testosterone-resistance (HTR) sub-lines.
• Evaluated in vitro and in vivo responses to testosterone and withdrawal in CRPC and HTR lines.

Main Results:

• Demonstrated differential responses of CRPC lines to high-dose testosterone.
• Confirmed resistance of HTR lines to testosterone and varied responses to testosterone withdrawal.
• Correlated heterogeneity in hormonal response with androgen receptor expression levels.

Conclusions:

• Successfully developed three novel HTR CRPC models.
• These models are valuable tools for elucidating mechanisms of testosterone resistance.
• The models can aid in identifying novel therapeutic targets for resistant prostate cancer.